Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Non-small cell lung cancer (NSCLC) remains a significant clinical challenge.
• Circular RNAs (circRNAs) are increasingly implicated in NSCLC pathogenesis, but their regulatory roles require further elucidation.
• Understanding circRNA mechanisms is crucial for developing novel NSCLC therapies.

Purpose of the Study:

• To investigate the role and mechanism of a specific circRNA, hsa_circ_0006677 (circ_0006677), in non-small cell lung cancer (NSCLC).
• To determine if circ_0006677 functions as a tumor suppressor in NSCLC.
• To elucidate the molecular pathway involving circ_0006677, miR-1245a, and SATB2 in NSCLC progression.

Main Methods:

• Bioinformatic analysis of NSCLC datasets (GSE158695, GSE112214) to identify differentially expressed circRNAs.
• Quantitative real-time PCR (RT-qPCR) to assess circ_0006677 expression.
• In vitro assays (clonogenic, EdU, flow cytometry, transwell, sphere formation) to evaluate the functional impact of circ_0006677.
• Bioinformatics, dual-luciferase reporter, and RIP assays to investigate the molecular mechanism.
• In vivo xenograft tumor models to validate findings.

Main Results:

• Circ_0006677 was found to be significantly downregulated in NSCLC tissues and cells.
• Overexpression of circ_0006677 suppressed NSCLC cell proliferation, migration, invasion, and stemness, while promoting apoptosis.
• Circ_0006677 acts as a molecular sponge for miR-1245a, thereby regulating SATB2 expression.
• miR-1245a or SATB2 manipulation affected the tumor-suppressive functions mediated by circ_0006677.

Conclusions:

• Circ_0006677 functions as a tumor suppressor in NSCLC.
• The circ_0006677/miR-1245a/SATB2 axis represents a novel regulatory mechanism in NSCLC progression.
• Circ_0006677 holds potential as a therapeutic target for NSCLC treatment.